Trial intelligence / Profile preview

Intravenous N-acetylcysteine in cirrhotic patients undergoing major abdominal surgery

PACTR201501001018282Completed

Sponsor
National Liver Institute
Start
Jan 2013
Modality
Small Molecules
Countries
1
01

Overview

Trial of acetylcysteine in Cirrhosis (2 arms), sponsored by National Liver Institute. Primary endpoints: Serum cystatin C and Cystatin C estimated glomerular filtration rate. Started Jan 2013; status: completed.

02

Drugs

acetylcysteine
03

Conditions

Cirrhosis

Beyond the preview

Go deeper on PACTR201501001018282.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201501001018282.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call